设为首页 加入收藏

TOP

KADCYLA (trastuzumab emtansine) injection(十九)
2014-07-17 15:40:02 来源: 作者: 【 】 浏览:7491次 评论:0
ion Only
Reconstitute and Dilute prior
to administration
Single-Dose Vial –
Discard Unused Portion

KEEP REFRIGERATED

Rx only

1 vial
 
Genentech

10135258
 
PRINCIPAL DISPLAY PANEL - 160 mg Vial Label

NDC 50242-087-01
 
Kadcyla™
(ado-trastuzumab
emtansine)
For Injection
 
160 mg per vial

For Intravenous Infusion Only
Reconstitute and Dilute prior
to administration
Single-Dose Vial –
Discard Unused Portion

KEEP REFRIGERATED

Rx only

1 vial
 
Genentech

4862100
 KADCYLA 
trastuzumab emtansine injection, powder, lyophilized, for solution
 Product Information
 
Product Type

HUMAN PRESCRIPTION DRUG LABEL

Item Code (Source)

NDC:50242-088
 
Route of Administration

INTRAVENOUS

DEA Schedule

 Active Ingredient/Active Moiety
 
Ingredient Name

Basis of Strength

Strength

TRASTUZUMAB EMTANSINE (TRASTUZUMAB EMTANSINE)

TRASTUZUMAB EMTANSINE

20 mg  in 1 mL
 
Inactive Ingredients
 
Ingredient Name

Strength
 
SUCROSE

60 mg  in 1 mL
 
SUCCINIC ACID

1.18 mg  in 1 mL
 
SODIUM HYDROXIDE

0.45 mg  in 1 mL
 
POLYSORBATE 20

0.2 mg  in 1 mL

WATER

 Packaging
#

Item Code

Package Description
1

NDC:50242-088-01

1 in 1 CARTON
 
1
5 mL in 1 VIAL, SINGLE-USE 

Marketing Information
 
Marketing Category

Application Number or Monograph Citation

Marketing Start Date

Marketing End Date
 
BLA

BLA125427

02/22/2013

 KADCYLA 
trastuzumab emtansine injection, powder, lyophilized, for solution
 Product Information
 
Product Type

HUMAN PRESCRIPTION DRUG LABEL

Item Code (Source)

NDC:50242-087
 
Route of Administration

INTRAVENOUS

DEA Schedule 

Active Ingredient/Active Moiety
 
Ingredient Name

Basis of Strength

Strength
TRASTUZUMAB EMTANSINE (TRASTUZUMAB EMTANSINE)

TRASTUZUMAB EMTANSINE

20 mg  in 1 mL
Inactive Ingredients
 
Ingredient Name

Strength
 
SUCROSE

60 mg  in 1 mL
 
SUCCINIC ACID

1.18 mg  in 1 mL
 
SODIUM HYDROXIDE

0.45 mg  in 1 mL
 
POLYSORBATE 20

0.2 mg  in 1 mL
 
WATER

 Packaging

Item Code

Package Description
 1

NDC:50242-087-01

1 in 1 CARTON
 
1
8 mL in 1 VIAL, SINGLE-USE
 Marketing Information

Marketing Category

Application Number or Monograph Citation

Marketing Start Date

Marketing End Date


BLA

BLA125427

02/22/2013
Labeler - Genentech, Inc. (080129000)
Establishment

Name

Address

ID/FEI

Business Operations

Genentech, Inc. (Hillsboro)
833220176

LABEL(50242-088, 50242-087), PACK(50242-088, 50242-087) 

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 16 17 18 19 下一页 尾页 19/19/19
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇特立氟胺胶囊TAFINLAR (dabrafeni.. 下一篇NESINA (alogliptin) tablet, fil..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位